Resmetirom Reduces Liver, CV Risk Factors in NASH With Cirrhosis

WASHINGTON — In patients with cirrhosis associated with non-alcoholic steatohepatitis (NASH), 1 year of treatment with the investigational oral thyromimetic agent resmetirom (MGL-3196) was safe and effective at lowering markers of both cardiovascular risk and NASH fibrosis, new research has found. Two cohorts comprising a total of 180 patients with well-compensated NASH cirrhosis enrolled in an open-label arm of the […]

Continue reading »

Post ‘Roe,’ Contraceptive Failures Carry Bigger Stakes

Birth control options have improved over the decades. Oral contraceptives are now safer, with fewer side effects. Intrauterine devices can prevent pregnancy 99.6% of the time. But no prescription drug or medical device works flawlessly, and people’s use of contraception is inexact. “No one walks into my office and says, ‘I plan on missing a pill,’” said obstetrician-gynecologist Dr. Mitchell […]

Continue reading »

Climate Change Could Destroy 90% of Marine Life by 2100

Up to 90% of all marine life across the globe could face extinction by 2100 if drastic measures aren’t taken to reduce greenhouse gases, according to an international team of researchers reporting in Nature Climate Change. What to know: Under the high greenhouse emissions currently being observed, global atmospheric temperatures will increase 3-5 °C in the next 80 years, and […]

Continue reading »

Digital nudges encourage more exercise

Text messages, app alerts and emails—so-called “digital nudges”—are effective at pushing us to do things, even exercise. New University of Minnesota research shows these actions used by corporate wellness programs lead to increased exercise among participants. A majority of large employers offer wellness programs to encourage healthy, active lifestyles among their employees. However, these programs often face low participation. Carlson […]

Continue reading »

First ever clinical trial of lab-grown red blood cells being transfused into another person

Cambridge researchers are taking part in the world’s first clinical trial of red blood cells that have been grown in a laboratory for transfusion into another person. The manufactured blood cells were grown from stem cells from donors. The red cells were then transfused into volunteers in the RESTORE randomized controlled clinical trial. This is the first time in the […]

Continue reading »
1 297 298 299 300 301 1,322